Alterity Therapeutics has outlined three priorities for 2026 following the successful completion in 2025 of a Phase II trial of ... Read More The post Alterity gears up for Phase III MSA trial, ...

Attention has turned to progressive supranuclear palsy, a rare neurodegenerative disorder. Here's what it is and why it's ...

As we get older, any number of things – from illness to medication, body confidence, relationship worries and family dynamics – can impact our sex lives.

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine Kinases (c-Abl kinases), announces publication of the ...

During the Boston Globe’s Rare Disease Summit, Dr. Wendy Chung, a physician-scientist and geneticist who leads the Department ...

Persistent inflammation may influence neurodegeneration through microglial activation, yet evidence remains hypothesis driven ...

“In GA, light is not transduced into electrical signals because of a loss of photoreceptors, which leads to an absolute scotoma (blind spot). 2,3 The PRIMA neurostimulation system replaces the lost ...

In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare ...

For photos, CLICK HEREFor b-roll, CLICK HERELAS VEGAS, Feb. 16, 2026 /PRNewswire/ -- Keep Memory Alive honored music legend Kenny Loggins at the 30th ...

Researchers identify the Functional-Structural Ratio (FSR) as the biological link between age-related hearing loss and cognitive decline, offering a potential new biomarker for dementia risk.

Doctors advised people with rheumatoid arthritis to manage the condition with an anti-inflammatory diet and appropriate cold ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.